Boston, Massachusetts 02116, United States
Ana Maria Cuervo, David Sinclair
Loss of proteostasis
small molecule drugs
Selphagy is a company co-founded by Ana Maria Cuervo, a researcher at Einstein College of Medicine. The company is developing small molecule drugs to enhance chaperone-mediated autophagy in order to treat neurodegenerative disease.